Pancreatic Cancer Research

ResearcherPhilipps University of MarburgActive in the last 2 years

Christian Alexander Bauer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1349-0160; OpenAlex author ID A5020113820. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 13

  1. Protocol for analyzing T cell and macrophage motility in a mouse pancreatic cancer spheroid model using light-sheet microscopy. Last author DOI 10.1016/j.xpro.2025.103981↗
  2. Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral T Cell Motility. Last author DOI 10.3390/cancers17010051↗
  3. IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Co-author DOI 10.1136/gutjnl-2022-327855↗
  4. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Last author DOI 10.1158/2326-6066.cir-22-0398↗
  5. IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. Last author DOI 10.3390/cells12030456↗
  6. The German National Case Collection for Familial Pancreatic Carcinoma (FaPaCa)—Knowledge Gained in 20 Years. Co-author DOI 10.3238/arztebl.m2021.0004↗
  7. The Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms21197307↗
  8. Stromal biology and therapy in pancreatic cancer: ready for clinical translation? First author DOI 10.1136/gutjnl-2018-316451↗
  9. Immunosuppressive βig-h3 links tumour stroma and dysfunctional T cells in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2018-317735↗
  10. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. Co-author DOI 10.3390/jcm7100295↗
  11. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.02.057↗
  12. Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity. Co-author DOI 10.1097/cji.0000000000000073↗
  13. Strategies to relieve immunosuppression in pancreatic cancer. Co-author DOI 10.2217/imt.15.9↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Mathias Gress · 8 shared papers, 2016–2024 · strength 1.10
  2. Malte Buchholz · 6 shared papers, 2019–2024 · strength 0.89
  3. Magdalena Huber · 5 shared papers, 2020–2024 · strength 0.79
  4. Vanessa Zimmer · 2 shared papers, 2024–2025 · strength 0.58
  5. Benedikt Slusny · 2 shared papers, 2024–2025 · strength 0.58
  6. Veronika Lutz · 3 shared papers, 2023–2024 · strength 0.49
  7. Elena Nasiri · 2 shared papers, 2023–2024 · strength 0.41
  8. Matthias Lauth · 3 shared papers, 2019–2023 · strength 0.33
  9. Detlef Klaus Bartsch · 3 shared papers, 2018–2023 · strength 0.32
  10. Peter Duewell · 4 shared papers, 2015–2023 · strength 0.32
  11. Emily P. Slater · 3 shared papers, 2018–2021 · strength 0.31
  12. Felix S.R. Picard · 2 shared papers, 2023 · strength 0.27
  13. Ioannis Mintziras · 2 shared papers, 2018–2021 · strength 0.20
  14. Elke Pogge von Strandmann · 2 shared papers, 2018–2020 · strength 0.17
  15. Max M. Schnurr · 3 shared papers, 2015–2016 · strength 0.17
  16. Corinna Ulrike Keber · 1 shared paper, 2023 · strength 0.15
  17. Peter Langer · 1 shared paper, 2021 · strength 0.13
  18. Anna I. Brichkina · 1 shared paper, 2023 · strength 0.12
  19. Shiv K. Singh · 1 shared paper, 2023 · strength 0.12
  20. Matthias M. Gaida · 1 shared paper, 2023 · strength 0.12
  21. Philipp Mayer · 1 shared paper, 2023 · strength 0.12
  22. Lukas Klein · 1 shared paper, 2023 · strength 0.12
  23. Mengyu Tu · 1 shared paper, 2023 · strength 0.12
  24. Robert Liefke · 1 shared paper, 2023 · strength 0.12
  25. Bilal Alashkar Alhamwe · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.